Retrospectively calculating the binding free energies for 59 ligands across four FBDD campaigns, we aim to investigate whether; a) ABFEs offer comparable results to in vitro affinity measures, and b) ABFEs could be used to achieve similar synthetic decisions in fragment optimisation. We also look at how ABFEs compare against cheaper methods, namely Nwat-MM/GBSA .